MCID: BNG002
MIFTS: 32

Benign Meningioma malady

Categories: Genetic diseases, Cancer diseases, Neuronal diseases, Rare diseases, Endocrine diseases

Aliases & Classifications for Benign Meningioma

About this section

Aliases & Descriptions for Benign Meningioma:

Name: Benign Meningioma 10 47 12 65
 
Meningioma, Benign 10

Classifications:



External Ids:

Disease Ontology10 DOID:4587
MeSH36 D008579
NCIt42 C4055
UMLS65 C0281784

Summaries for Benign Meningioma

About this section
MalaCards based summary: Benign Meningioma, also known as meningioma, benign, is related to pulmonary sclerosing hemangioma and pituitary stalk meningioma. An important gene associated with Benign Meningioma is NF2 (Neurofibromin 2 (Merlin)). Affiliated tissues include brain, breast and lung.

Related Diseases for Benign Meningioma

About this section

Diseases in the Benign Meningioma family:

Meningioma, Familial Familial Multiple Meningioma

Diseases related to Benign Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 51)
idRelated DiseaseScoreTop Affiliating Genes
1pulmonary sclerosing hemangioma10.6NF2, PGR
2pituitary stalk meningioma10.6NF2, PGR
3corneal neovascularization10.6NF2, PGR
4pyelonephritis10.6NF2, PGR
5skull base meningioma10.6NF2, PGR
6fibrous meningioma10.6MKI67, NF2
7third ventricle chordoid glioma10.5NF2, TERT
8breast papillomatosis10.5MKI67, PGR
9rectum mucinous adenocarcinoma10.5MKI67, PGR
10ovarian clear cell adenocarcinoma10.5MKI67, PGR
11immune system cancer10.5MKI67, PGR
12osteoblastoma10.5MKI67, PGR
13lymphoplasmacyte-rich meningioma10.4MKI67, NF2
14uterine inflammatory disease10.4CTSL, TERT
15uterine corpus adenosarcoma10.4BIRC5, PGR
16intracerebral cystic meningioma10.4NF2, PGR
17breast leiomyoma10.4MKI67, PGR
18male reproductive organ benign neoplasm10.3NF2, PGR
19deep leiomyoma10.3PCNA, PGR
20vitreous detachment10.3CTSL, TERT
21dermato-cardio-skeletal syndrome, borrone type10.3BIRC5, TERT
22autosomal dominant complex spastic paraplegia type 9a10.3BIRC5, MKI67
23distal monosomy 9p10.3BIRC5, NF2
24familial short qt syndrome10.3BIRC5, NF2
25oral lichen planus10.2MKI67, PCNA
26locked-in syndrome10.2NF2, PCNA
27grayson-wilbrandt corneal dystrophy10.2PCNA, PGR
28selective igg deficiency disease10.2MKI67, PCNA
29bowenoid papulosis10.2MKI67, PCNA
30prostatic cyst10.2PCNA, PGR
31progressive muscular atrophy10.2MKI67, PCNA
32levator syndrome10.2MKI67, PCNA
33cervical adenoid cystic carcinoma10.1PCNA, PGR
34preretinal fibrosis10.1NF2, PCNA
35larynx sarcoma10.0MKI67, PGR
36meningioma, familial10.0
37cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction10.0BIRC5, MKI67, TERT
38desmoplastic infantile astrocytoma10.0MKI67, PCNA
39brain edema9.9
40uterine corpus endometrial stromal sarcoma9.9PCNA, PGR
41juxtacortical chondroma9.9MKI67, PCNA, TERT
42myoclonic cerebellar dyssynergia9.9MKI67, PGR
43bone ameloblastoma9.8PCNA, TERT
44cervical cancer, somatic9.8MKI67, PCNA, TERT
45hemangiopericytoma9.8
46paroxysmal choreoathetosis9.8BIRC5, PCNA
47cerebral amyloid angiopathy9.7
48cerebritis9.7
49muscular dystrophy-dystroglycanopathy , type a, 29.6MKI67, PCNA, PGR, TERT
50autoimmune lymphoproliferative syndrome8.8CTSL, MKI67, NF2, PCNA, PGR, TERT

Graphical network of the top 20 diseases related to Benign Meningioma:



Diseases related to benign meningioma

Symptoms for Benign Meningioma

About this section

Drugs & Therapeutics for Benign Meningioma

About this section

Drugs for Benign Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxyureaapprovedPhase 2188127-07-13657
Synonyms:
1-HYDROXYUREA
127-07-1
4-03-00-00170 (Beilstein Handbook Reference)
55291_FLUKA
AC1L1GF8
AC1Q4ZXK
AI3-51139
BB_SC-7256
BRN 1741548
BSPBio_002164
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
C07044
CCRIS 958
CHEBI:44423
CHEMBL467
CID3657
Carbamohydroxamic Acid
Carbamohydroxamic acid
Carbamohydroximic Acid
Carbamohydroximic acid
Carbamohydroxyamic Acid
Carbamohydroxyamic acid
Carbamoyl Oxime
Carbamoyl oxime
Carbamyl Hydroxamate
Carbamyl hydroxamate
Carrbamoyl Oxime
D00341
D006918
DB01005
DRG-0253
DivK1c_000556
Droxia
Droxia (TM)
Droxia (TN)
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EINECS 204-821-7
EU-0100596
FT-0083575
H 8627
H0310
H20210
H8627_SIGMA
HMS1920F09
HMS2091L17
HMS501L18
HSDB 6887
HU
HYDREA (TN)
HYDROXY-UREA
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
Hydrea
Hydrea (TM)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamide (JAN/INN)
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
Hydroxylurea
Hydroxyurea
Hydroxyurea (D4)
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea(d4)
 
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [DCIT]
Idrossicarbamide [Dcit]
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
LS-709
Litaler
Litalir
Lopac-H-8627
Lopac0_000596
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-Carbamoylhydroxylamine
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
NCGC00015520-01
NCGC00015520-02
NCGC00015520-07
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
NCI C04831
NCI-C04831
NCI60_002773
NCIMech_000139
NHY
NINDS_000556
NSC 32065
NSC32065
Onco-Carbide
Onco-carbide
Oncocarbide
Oxyurea
S-phase/G-1 interface inhibitor
S1896_Selleck
SK 22591
SMR000059149
SPBio_000247
SPECTRUM1500344
SQ 1089
SQ-1089
Siklos
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
Spectrum_000909
Sterile Urea
TL8000673
UNII-X6Q56QN5QC
Ureaphil
WLN: ZVMQ
carbamide oxide
hydroxyaminomethanamide
hydroxyurea
nchembio.573-comp3
nchembio.90-comp4
nchembio749-comp3
tetratogen: inhibits ribonucleoside diphosphate reductase
2
Lapatinibapproved, investigational, Approved March 2007Phase 2294231277-92-2, 388082-78-8208908, 9941095
Synonyms:
1xkk
231277-92-2
388082-78-8
4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline
AB1004631
AC-1314
AC1L4LL4
AKOS005145766
CHEBI:49603
CHEMBL1201179
CHEMBL554
CID11557040
CID208908
D04024
D08108
DB01259
DB02584
EN002712
FMM
GSK 572016
GSK572016
GW 572016
GW 572016X
GW-2016
GW-572016
GW-572016F
GW2016
GW572016
HMS2089H10
I01-1247
 
Kinome_3684
Kinome_3685
LAPATINIB DITOSYLATE MONOHYDRATE
LS-187029
LS-187771
Lapatinib
Lapatinib (INN)
Lapatinib Ditosylate
Lapatinib [INN]
Lapatinib ditosylate
Lapatinib ditosylate (USAN)
Lapatinib tosilate hydrate
Lapatinib tosilate hydrate (JAN)
Lapatinib, Tykerb, GW572016
N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine
N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine
N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
NCGC00167507-01
NSC745750
TL80090051
Tycerb
Tykerb
Tykerb (TN)
Tyverb
UNII-0VUA21238F
lapatinib
lapatinib ditosylate
nchembio866-comp20
3interferonsPhase 21930
4Iron-Dextran ComplexPhase 267
5Protein Kinase InhibitorsPhase 23162
6Interferon-alphaPhase 21028
7Nucleic Acid Synthesis InhibitorsPhase 23836
8Immunologic FactorsPhase 218483
9Anti-Infective AgentsPhase 217220
10Antiviral AgentsPhase 28071
11
Pioglitazoneapproved, investigationalPhase 1419111025-46-84829
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione
105355-27-9
111025-46-8
198077-89-3
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
AB1004597
AC-1021
AC1L1J1Q
AD 4833
AD-4833
Actos
Actos (TN)
Actost
BRD-A48430263-003-02-4
BSPBio_002723
C07675
C19H20N2O3S
CHEBI:8228
CHEMBL595
CID4829
D08378
DB01132
Duetact
Glustin
HMS2089H14
HS-0047
 
HSDB 7322
I06-0089
KBio2_002103
KBio2_004671
KBio2_007239
KBio3_001943
KBioGR_001619
KBioSS_002103
LS-151327
MolPort-002-508-211
NCGC00163128-01
NCGC00163128-02
Pioglitazona
Pioglitazona [INN-Spanish]
Pioglitazone
Pioglitazone HCl
Pioglitazone Hydrochloride
Pioglitazone [BAN:INN]
Pioglitazone [Ban:Inn]
Pioglitazone [INN:BAN]
Pioglitazonum
Pioglitazonum [INN-Latin]
SPBio_001897
Spectrum2_001679
Spectrum3_001002
Spectrum4_001130
Spectrum5_001480
Spectrum5_002067
Spectrum_001623
U 72107
U 72107A
U-72107
U72,107A
UNII-X4OV71U42S
Zactos
nchembio790-comp10
pioglitazone (INN)
pioglitazone HCl
12Hypoglycemic AgentsPhase 14503

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Stereotactic Body Radiotherapy for Spine TumorsActive, not recruitingNCT01347307Phase 4
2SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain TumorsActive, not recruitingNCT00517959Phase 3
3Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by SurgeryTerminatedNCT00104936Phase 3
4S9811 Hydroxyurea in Treating Patients With Unresectable Benign MeningiomaCompletedNCT00003590Phase 2
5Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant MeningiomasCompletedNCT00002965Phase 2
6Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT00973739Phase 2
7Multisession Radiosurgery for Optic Nerve Sheath MeningiomasRecruitingNCT02594709Phase 2
8Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
9A Family Study of Adults With GliomaCompletedNCT00339352
10Analysis of NF2 Mutations in Radiation-Related Neural TumorsCompletedNCT00340496
11A Case-Referent Study of Brain Tumors in AdultsCompletedNCT00339300
12Risk Factors for Adult-Onset Brain TumorsEnrolling by invitationNCT00592865

Search NIH Clinical Center for Benign Meningioma

Genetic Tests for Benign Meningioma

About this section

Anatomical Context for Benign Meningioma

About this section

MalaCards organs/tissues related to Benign Meningioma:

33
Brain, Breast, Lung, Pituitary, Prostate, Endothelial, T cells

Animal Models for Benign Meningioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Benign Meningioma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Benign Meningioma

About this section

Articles related to Benign Meningioma:

(show all 41)
idTitleAuthorsYear
1
A case of benign meningioma presented with subdural hemorrhage. (25977904)
2015
2
Cerebral amyloid angiopathy-related infarcts imitating high-grade differentiation of a benign meningioma. (26385916)
2015
3
Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients. (24813096)
2014
4
Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients. (24751409)
2014
5
Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma. (23840654)
2013
6
Impaired survival and long-term neurological problems in benign meningioma. (22406926)
2012
7
Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. (22285662)
2012
8
Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. (23285163)
2012
9
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas. (22420586)
2012
10
Is a benign meningioma always an indolent tumor? (21486754)
2011
11
Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. (20428925)
2010
12
Quantitative evaluation of benign meningioma and hemangiopericytoma with peritumoral brain edema by 64-slice CT perfusion imaging. (20819539)
2010
13
Benign meningioma developing late lung metastases: case report and review of the literature. (19919820)
2009
14
How a Brain Tumour took over my Life: Diagnosis and removal of a benign meningioma. (21509301)
2009
15
Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. (18586307)
2008
16
Iatrogenic metastasis of a benign meningioma to the periosteum at the site of previous craniotomy: a case report. (19122989)
2008
17
Gamma Knife surgery for benign meningioma. (17695387)
2007
18
Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas? (17961045)
2007
19
Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. (15980114)
2006
20
Protein p62 common in invaginations in benign meningiomas--a possible predictor of malignancy. (16465773)
2006
21
PCNA, Ki-67 and hTERT in residual benign meningiomas. (16634530)
2006
22
Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. (15832773)
2005
23
Establishment of a benign meningioma cell line by hTERT-mediated immortalization. (15965488)
2005
24
Proliferation and progesterone receptor status in benign meningiomas are not age dependent. (15952201)
2005
25
Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. (16029801)
2005
26
Expression of the inhibitor of apoptosis protein survivin in benign meningiomas. (12706880)
2003
27
Expression of extracellular matrix markers in benign meningiomas. (14719542)
2003
28
Benign meningioma metastasizing through CSF pathways: a case report and review of literature. (12391463)
2002
29
Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein. (11928726)
2002
30
Overexpression of mdm2 and p53 and association with progesterone receptor expression in benign meningiomas. (12416559)
2002
31
The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. (12224136)
2002
32
Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence. (11299001)
2001
33
Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. (11121635)
2000
34
An iatrogenic epidemic of benign meningioma. (10670551)
2000
35
Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? (10701525)
2000
36
Images in pathology. Benign meningioma. (10458841)
1999
37
Radiotherapy in the treatment of benign meningioma of the skull base. (10223446)
1999
38
Hemangiopericytoma arising at the site of a dural graft 13 years after total removal of a benign meningioma--case report. (9919906)
1998
39
Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas. (10066099)
1998
40
Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. (9352816)
1997
41
Benign meningioma with a short latency period following irradiation. (1440212)
1992

Variations for Benign Meningioma

About this section

Expression for genes affiliated with Benign Meningioma

About this section
Search GEO for disease gene expression data for Benign Meningioma.

Pathways for genes affiliated with Benign Meningioma

About this section

GO Terms for genes affiliated with Benign Meningioma

About this section

Sources for Benign Meningioma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet